` 1501 (Shanghai Kindly Medical Instruments Co Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

1501
vs
Hang Seng (Hong Kong)

Over the past 12 months, has underperformed Hang Seng (Hong Kong), delivering a return of -2% compared to the Hang Seng (Hong Kong)'s 19% growth.

Stocks Performance
1501 vs Hang Seng (Hong Kong)

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
1501 vs Hang Seng (Hong Kong)

Loading
1501
Hang Seng (Hong Kong)
Difference

Performance By Year
1501 vs Hang Seng (Hong Kong)

Loading
1501
Hang Seng (Hong Kong)
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Shanghai Kindly Medical Instruments Co Ltd vs Peers

Hang Seng (Hong Kong)
1501
7741
ALC
COLO B
ALGN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Shanghai Kindly Medical Instruments Co Ltd
Glance View

Market Cap
4.8B HKD
Industry
Health Care

Shanghai Kindly Medical Instruments Co., Ltd. engages in manufacturing, selling, research and development of cardiovascular interventional devices in China. The company is headquartered in Shanghai, Shanghai and currently employs 1,189 full-time employees. The company went IPO on 2019-11-08. The firm's cardiovascular intervention business is mainly engaged in the development, production and sales of cardiovascular interventional medical devices and related molds and accessories. The firm is also engaged in the development of other interventional and implantable medical devices, such as neurological interventional medical devices and endocardia implantable medical devices. The firm's main products include inflation device, Introducer set, guidewire and so on. The firm operates its business within the domestic market and to overseas markets including Europe and the United States.

Intrinsic Value
30.62 HKD
Undervaluation 12%
Intrinsic Value
Price
S
Back to Top